trending Market Intelligence /marketintelligence/en/news-insights/trending/ub5tq5yxr7pr7qgimwzilq2 content esgSubNav
In This List

Rakuten invests in Japanese genetic testing company Genesis

Blog

Japan M&A By the Numbers: Q1 2022

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

SEC Climate Disclosure Requirements Heating Up: How to Take Action


Rakuten invests in Japanese genetic testing company Genesis

Japanese genetic testing company Genesis Healthcare Co. said Feb. 27 that online retailer Rakuten Inc. and Omron Healthcare Co. Ltd. invested in Genesis to bring its valuation to ¥42 billion.

The details of the investment were not disclosed. Genesis said that this was Rakuten's second investment in Genesis. The retailer bought about ¥1.4 billion worth of Genesis shares in August 2017.

As of Feb. 26, US$1 was equivalent to ¥106.92.